CRISPR/Cas9 Genome-Editing System in Human Stem Cells: Current Status and Future Prospects
Genome-editing involves the insertion, deletion, or replacement of DNA in the genome of a living organism using "molecular scissors." Traditional genome editing with engineered nucleases for human stem cells is limited by its low efficiency, high cost, and poor specificity. The CRISPR syst...
Saved in:
Main Authors: | Zhao Zhang (Author), Yuelin Zhang (Author), Fei Gao (Author), Shuo Han (Author), Kathryn S. Cheah (Author), Hung-Fat Tse (Author), Qizhou Lian (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2017-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CRISPR/Cas9: Transcending the Reality of Genome Editing
by: Sergiu Chira, et al.
Published: (2017) -
The Rise of CRISPR/Cas for Genome Editing in Stem Cells
by: Bing Shui, et al.
Published: (2016) -
CRISPR/Cas9-mediated genome editing in nonhuman primates
by: Yu Kang, et al.
Published: (2019) -
CRISPR/Cas9 Delivery System Engineering for Genome Editing in Therapeutic Applications
by: Hao Cheng, et al.
Published: (2021) -
HIT-Cas9: A CRISPR/Cas9 Genome-Editing Device under Tight and Effective Drug Control
by: Chen Zhao, et al.
Published: (2018)